- The Reported Group revenues in the first quarter increased by 9 per cent over the comparable period. Group revenues increased by 11 per cent on CER basis, with acquisitions completed last year contributing 9 per cent, while the underlying growth was of 2 per cent.
- The Group's operating margin in the first quarter remained in line with expectations.
- The company reported that revenues on a reported and underlying basis of Life Sciences Sector were up 2 per cent and 3 per cent respectively.
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.